KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $0.01.

  • TherapeuticsMD's EPS (Basic) rose 12000.0% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 10357.14%. This contributed to the annual value of $11.36 for FY2024, which is 10459.89% up from last year.
  • Per TherapeuticsMD's latest filing, its EPS (Basic) stood at $0.01 for Q3 2025, which was up 12000.0% from $0.05 recorded in Q2 2025.
  • TherapeuticsMD's 5-year EPS (Basic) high stood at $63.02 for Q4 2023, and its period low was -$5.7 during Q1 2022.
  • Over the past 5 years, TherapeuticsMD's median EPS (Basic) value was -$0.09 (recorded in 2024), while the average stood at $3.38.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 458333.33% in 2021, then soared by 333980.95% in 2022.
  • Over the past 5 years, TherapeuticsMD's EPS (Basic) (Quarter) stood at -$0.1 in 2021, then skyrocketed by 3339.81% to $3.24 in 2022, then soared by 1845.2% to $63.02 in 2023, then crashed by 81.01% to $11.97 in 2024, then crashed by 99.92% to $0.01 in 2025.
  • Its last three reported values are $0.01 in Q3 2025, $0.05 for Q2 2025, and -$0.06 during Q1 2025.